Vesugen Research Guide

Full name: Vesugen (Lys-Glu-Asp Vascular Bioregulator)

A short synthetic tripeptide bioregulator from the Khavinson family, targeted at vascular tissue. It is used within the peptide-bioregulator community for vascular health and endothelial support, typically in short repeated courses.

How Vesugen Works

As a signal peptide (Lys-Glu-Asp), it is proposed to enter cells and regulate gene expression in vascular tissue, supporting endothelial function, vascular tone, and normal vessel-wall maintenance.

Dosing Protocol

• Typical dose: ~1-2 capsules/day or short injectable courses
• Frequency: Once daily
• Duration: 10-30 day courses
• Route: Oral capsule or subcutaneous

Reported Benefits

• Vascular/endothelial support
• Proposed vascular tissue regulation
• Short course-based protocol
• Part of bioregulator longevity systems

Potential Side Effects

• Limited Western clinical data
• Injection site reactions (injectable)
• Unknown long-term effects

Research Citations

1. Peptide bioregulators and vascular tissue (2018) - Short peptide bioregulators were reported to influence gene expression and tissue-specific function in Russian research programs.

Related Cardiovascular Compounds

• Nattokinase - Full Profile
• Serrapeptase - Full Profile
• CoQ10 - Full Profile
• Omega-3 (EPA/DHA) - Full Profile
• Bergamot Extract - Full Profile
• Telmisartan - Full Profile

View full Vesugen profile with 3D molecule viewer →